Current Cancer Biomarkers 1st Edition

Grab the definitive resource for contemporary oncology practice: Current Cancer Biomarkers 1st Edition by Farhadul Islam. This essential title cuts through complexity to deliver clear, evidence-based insight into the biomarkers transforming cancer diagnosis, prognosis, and treatment monitoring.

Dive into a meticulously organized guide that explores genomic, proteomic, and immunologic biomarkers, plus cutting-edge topics such as liquid biopsy, circulating tumor DNA, and biomarker-driven clinical trials. Each chapter bridges basic science and clinical application, making complex molecular data accessible to oncologists, pathologists, clinical researchers, and advanced students.

What sets this volume apart is its practical focus: it highlights biomarkers’ roles in personalized medicine, illustrates assay selection and interpretation, and discusses regulatory and validation considerations. Readers gain actionable knowledge for precision oncology workflows, biomarker discovery programs, and translational research initiatives.

Perfectly suited for professionals and institutions across North America, Europe, Asia, Africa, and beyond, this book is an invaluable reference for clinical labs, cancer centers, and academic departments seeking to stay current with global advances in oncology biomarkers. Whether you’re implementing diagnostic panels, designing trials, or teaching the next generation of clinicians, this edition equips you with the tools to make informed decisions.

Order your copy of Current Cancer Biomarkers 1st Edition by Farhadul Islam today and bring cutting-edge biomarker science into your practice or research library—streamline diagnostics, refine therapeutic strategies, and advance patient-centered care with clarity and confidence.

Note: eBooks do not include supplementary materials such as CDs, access codes, etc.